{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:03:20Z","timestamp":1784851400743,"version":"3.55.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08297-6","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:35:16Z","timestamp":1779798916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sigma-1R\u2013CD36 axis in myeloid cells contributes to the alleviation of depression-like behaviors"],"prefix":"10.1186","volume":"24","author":[{"given":"Meng","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaonan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gencheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2404-0555","authenticated-orcid":false,"given":"Weidong","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"8297_CR1","doi-asserted-by":"publisher","first-page":"1084993","DOI":"10.3389\/fpsyt.2023.1084993","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, Liu Q, Yang X, Dou Y, Wang Y, Zhang Z, et al. Relationship of insight to neurocognitive function and risk of recurrence in depression: a naturalistic follow-up study. Front Psychiatry. 2023;14:1084993. https:\/\/doi.org\/10.3389\/fpsyt.2023.1084993.","journal-title":"Front. Psychiatry"},{"issue":"1","key":"8297_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"W Marx","year":"2023","unstructured":"Marx W, Penninx B, Solmi M, Furukawa TA, Firth J, Carvalho AF, et al. Major depressive disorder. Nat Rev Dis Primers. 2023;9(1):44. https:\/\/doi.org\/10.1038\/s41572-023-00454-1.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"8297_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","volume":"9","author":"L Cui","year":"2024","unstructured":"Cui L, Li S, Wang S, Wu X, Liu Y, Yu WWang Y, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Sig Transduct Target Ther. 2024;9(1):30. https:\/\/doi.org\/10.1038\/s41392-024-01738-y.","journal-title":"Sig Transduct Target Ther"},{"key":"8297_CR4","unstructured":"European Medicines Agency (EMA) C. Guideline on clinical investigation of medicinal products in the treatment of depression (revision 3). 2025."},{"key":"8297_CR5","doi-asserted-by":"publisher","unstructured":"He S, Chen JX, Yu X, Lin H, Wang Z, Li X, et al. Efficacy and safety of Ammoxetine in major depressive disorder: a randomized clinical trial. JAMA Netw Open. 2025;8(9):e2532650. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.32650.","DOI":"10.1001\/jamanetworkopen.2025.32650"},{"issue":"2","key":"8297_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s44220-023-00187-w","volume":"2","author":"CHY Fu","year":"2024","unstructured":"Fu CHY, Antoniades M, Erus G, Garcia JA, Fan Y, Arnone D, et al. Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo. Nat Ment Health. 2024;2(2):164\u201376. https:\/\/doi.org\/10.1038\/s44220-023-00187-w.","journal-title":"Nat Ment Health"},{"issue":"6","key":"8297_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1176\/appi.ajp.20250289","volume":"182","author":"AH Miller","year":"2025","unstructured":"Miller AH. Advancing an inflammatory subtype of major depression. AJP. 2025;182(6):516\u201324. https:\/\/doi.org\/10.1176\/appi.ajp.20250289.","journal-title":"AJP"},{"issue":"1","key":"8297_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41398-024-02921-z","volume":"14","author":"S Poletti","year":"2024","unstructured":"Poletti S, Mazza MG, Benedetti F. Inflammatory mediators in major depression and bipolar disorder. Transl Psychiatry. 2024;14(1):247. https:\/\/doi.org\/10.1038\/s41398-024-02921-z.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"8297_CR9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41380-022-01919-7","volume":"28","author":"\u00c9M Foley","year":"2023","unstructured":"Foley \u00c9M, Parkinson JT, Mitchell RE, Turner L, Khandaker GM. Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis. Mol. Psychiatry. 2023;28(3):1004\u201319. https:\/\/doi.org\/10.1038\/s41380-022-01919-7.","journal-title":"Mol. Psychiatry"},{"issue":"8001","key":"8297_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41586-023-07015-2","volume":"626","author":"F Cathomas","year":"2024","unstructured":"Cathomas F, Lin HY, Chan KL, Li L, Parise LF, Alvarez J, et al. Circulating myeloid-derived MMP8 in stress susceptibility and depression. Nature. 2024;626(8001):1108\u201315. https:\/\/doi.org\/10.1038\/s41586-023-07015-2.","journal-title":"Nature"},{"key":"8297_CR11","doi-asserted-by":"publisher","first-page":"100942","DOI":"10.1016\/j.bbih.2024.100942","volume":"43","author":"F Stolfi","year":"2025","unstructured":"Stolfi F, Brasso C, Raineri D, Landra V, Mazzucca CB, Ghazanfar A, et al. Deep immunophenotyping of circulating immune cells in major depressive disorder patients reveals immune correlates of clinical course and treatment response. Brain Behav Immun - Health. 2025;43:100942. https:\/\/doi.org\/10.1016\/j.bbih.2024.100942.","journal-title":"Brain Behav Immun - Health"},{"key":"8297_CR12","doi-asserted-by":"publisher","first-page":"1693999","DOI":"10.3389\/fncel.2025.1693999","volume":"19","author":"KM Ryan","year":"2025","unstructured":"Ryan KM, O\u2019Rourke A, Sheridan C, Balcells Quintana M, Moran B, Fletcher JM, et al. Flow-cytometric analysis of immune cell populations in patients with depression: relationship with depression severity and electroconvulsive therapy therapeutic outcomes. Front Cell Neurosci. 2025;19:1693999. https:\/\/doi.org\/10.3389\/fncel.2025.1693999.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"8297_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","volume":"21","author":"WC Drevets","year":"2022","unstructured":"Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nat Rev Drug Discov. 2022;21(3):224\u201344. https:\/\/doi.org\/10.1038\/s41573-021-00368-1.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"8297_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41398-025-03601-2","volume":"15","author":"A Lengvenyte","year":"2025","unstructured":"Lengvenyte A, Blaquiere M, Dubois J, Bonnin M, Bourret J, Hamzeh-Cognasse H, et al. Integrating cellular and soluble immune signatures of major depression with and without recent suicide attempts. Transl Psychiatry. 2025;15(1):377. https:\/\/doi.org\/10.1038\/s41398-025-03601-2.","journal-title":"Transl Psychiatry"},{"key":"8297_CR15","doi-asserted-by":"publisher","unstructured":"Chen Y, Zhang J, Cui W, Silverstein RL. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J Exp Med. 2022;219(6). https:\/\/doi.org\/10.1084\/jem.20211314.","DOI":"10.1084\/jem.20211314"},{"key":"8297_CR16","doi-asserted-by":"publisher","unstructured":"Carrera P, Odenthal J, Risse KS, Jung Y, Kuerschner L, B\u00fclow MH. The CD36 scavenger receptor Bez regulates lipid redistribution from fat body to ovaries in Drosophila. Development. 2024;151(9). https:\/\/doi.org\/10.1242\/dev.202551.","DOI":"10.1242\/dev.202551"},{"key":"8297_CR17","doi-asserted-by":"publisher","first-page":"1531171","DOI":"10.3389\/fimmu.2025.1531171","volume":"16","author":"C Mata-Cruz","year":"2025","unstructured":"Mata-Cruz C, Guerrero-Rodr\u00edguez SL, G\u00f3mez-Castellano K, Carballo-Uicab G, Almagro JC, P\u00e9rez-Tapia SM, et al. Discovery and in vitro characterization of a human anti-CD36 scFv. Front Immunol. 2025;16:1531171. https:\/\/doi.org\/10.3389\/fimmu.2025.1531171.","journal-title":"Front Immunol"},{"issue":"2","key":"8297_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00011.2023","volume":"104","author":"JFC Glatz","year":"2024","unstructured":"Glatz JFC, Heather LC, Luiken J. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Physiol Rev. 2024;104(2):727\u201364. https:\/\/doi.org\/10.1152\/physrev.00011.2023.","journal-title":"Physiol Rev"},{"issue":"1","key":"8297_CR19","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1038\/s41467-023-39752-3","volume":"14","author":"VS Peche","year":"2023","unstructured":"Peche VS, Pietka TA, Jacome-Sosa M, Samovski D, Palacios H, Chatterjee-Basu G, et al. Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels. Nat Commun. 2023;14(1):4029. https:\/\/doi.org\/10.1038\/s41467-023-39752-3.","journal-title":"Nat Commun"},{"issue":"1","key":"8297_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41392-024-01840-1","volume":"9","author":"R Chen","year":"2024","unstructured":"Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Sig Transduct Target Ther. 2024;9(1):130. https:\/\/doi.org\/10.1038\/s41392-024-01840-1.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"8297_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Sig Transduct Target Ther. 2022;7(1):131. https:\/\/doi.org\/10.1038\/s41392-022-00955-7.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"8297_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00011-013-0667-3","volume":"63","author":"W Liu","year":"2014","unstructured":"Liu W, Yin Y, Zhou Z, He M, Dai Y. OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation. Inflamm Res. 2014;63(1):33\u201343. https:\/\/doi.org\/10.1007\/s00011-013-0667-3.","journal-title":"Inflamm Res"},{"key":"8297_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuroscience.2020.11.003","volume":"453","author":"AM Dobri","year":"2021","unstructured":"Dobri AM, Dud\u0103u M, Enciu AM, Hinescu ME. CD36 in Alzheimer\u2019s disease: an overview of molecular mechanisms and therapeutic targeting. Neuroscience. 2021;453:301\u201311. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.11.003.","journal-title":"Neuroscience"},{"issue":"2","key":"8297_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","volume":"11","author":"CR Stewart","year":"2010","unstructured":"Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010;11(2):155\u201361. https:\/\/doi.org\/10.1038\/ni.1836.","journal-title":"Nat Immunol"},{"issue":"12","key":"8297_CR25","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1073\/pnas.1015413108","volume":"108","author":"L Park","year":"2011","unstructured":"Park L, Wang G, Zhou P, Zhou J, Pitstick R, Previti ML, et al. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-\u03b2. Proc Natl Acad Sci USA. 2011;108(12):5063\u201368. https:\/\/doi.org\/10.1073\/pnas.1015413108.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8297_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41398-022-02229-w","volume":"12","author":"JK Zaki","year":"2022","unstructured":"Zaki JK, Lago SG, Rustogi N, Gangadin SS, Benacek J, van Rees GF, et al. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Transl Psychiatry. 2022;12(1):457. https:\/\/doi.org\/10.1038\/s41398-022-02229-w.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"8297_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41537-024-00510-z","volume":"10","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liao A, Wang Y, Liu Q, Ouyang L, Peng H, et al. Profiling expressing features of surface proteins on single-exosome in first-episode schizophrenia patients: a preliminary study. Schizophr (Heidelb). 2024;10(1):84. https:\/\/doi.org\/10.1038\/s41537-024-00510-z.","journal-title":"Schizophr (Heidelb)"},{"issue":"1","key":"8297_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41398-020-01130-8","volume":"11","author":"S Bai","year":"2021","unstructured":"Bai S, Wang W, Wang T, Li J, Zhang S, Chen Z, et al. CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice. Transl Psychiatry. 2021;11(1):16. https:\/\/doi.org\/10.1038\/s41398-020-01130-8.","journal-title":"Transl Psychiatry"},{"key":"8297_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbr.2015.11.027","volume":"299","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wang W, Li J, Cheng K, Zhou J, Zhu D, et al. Behavioral characterization of CD36 knockout mice with SHIRPA primary screen. Behavioural Brain Res. 2016;299:90\u201396. https:\/\/doi.org\/10.1016\/j.bbr.2015.11.027.","journal-title":"Behavioural Brain Res"},{"issue":"1","key":"8297_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","volume":"118","author":"H Shu","year":"2022","unstructured":"Shu H, Peng Y, Hang W, Nie J, Zhou N, Wang DW. The role of CD36 in cardiovascular disease. Cardiovasc Res. 2022;118(1):115\u201329. https:\/\/doi.org\/10.1093\/cvr\/cvaa319.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"8297_CR31","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.1038\/s41467-025-61875-y","volume":"16","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Li J, Liu X, Chen X, Zhu L, Zhang Z, et al. Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy. Nat Commun. 2025;16(1):6602. https:\/\/doi.org\/10.1038\/s41467-025-61875-y.","journal-title":"Nat Commun"},{"issue":"2","key":"8297_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41589-023-01414-2","volume":"20","author":"LA Hehl","year":"2024","unstructured":"Hehl LA, Horn-Ghetko D, Prabu JR, Vollrath R, Vu DT, P\u00e9rez Berrocal DA, et al. Structural snapshots along K48-linked ubiquitin chain formation by the HECT E3 UBR5. Nat Chem Biol. 2024;20(2):190\u2013200. https:\/\/doi.org\/10.1038\/s41589-023-01414-2.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"8297_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Sig Transduct Target Ther. 2022;7(1):113. https:\/\/doi.org\/10.1038\/s41392-022-00966-4.","journal-title":"Sig Transduct Target Ther"},{"key":"8297_CR34","doi-asserted-by":"crossref","unstructured":"Hu X, Zhou T, Cui T, Du Y, Song C, Chang W, et al. SigmaR1 is an auxiliary translocon factor with lipid-binding activity that regulates protein and lipid droplet homeostasis. Nat Commun. 2025.","DOI":"10.1038\/s41467-025-68157-7"},{"issue":"1","key":"8297_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen X, Shi C, He M, Xiong S, Xia X. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Sig Transduct Target Ther. 2023;8(1):352. https:\/\/doi.org\/10.1038\/s41392-023-01570-w.","journal-title":"Sig Transduct Target Ther"},{"issue":"11","key":"8297_CR36","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1021\/acschemneuro.3c00206","volume":"14","author":"X Morat\u00f3","year":"2023","unstructured":"Morat\u00f3 X, Fern\u00e1ndez-Due\u00f1as V, P\u00e9rez-Villamor P, Valle-Le\u00f3n M, Vela JM, Merlos M, et al. Development of a novel \u03c3 1 receptor biosensor based on its heterodimerization with binding immunoglobulin protein in living cells. ACS Chem. Neurosci. 2023;14(11):2201\u201307. https:\/\/doi.org\/10.1021\/acschemneuro.3c00206.","journal-title":"ACS Chem. Neurosci"},{"issue":"20","key":"8297_CR37","doi-asserted-by":"publisher","first-page":"14997","DOI":"10.1021\/acs.jmedchem.1c00886","volume":"64","author":"G Rossino","year":"2021","unstructured":"Rossino G, Rui M, Linciano P, Rossi D, Boiocchi M, Peviani M, et al. Bitopic Sigma 1 receptor modulators to shed light on molecular mechanisms underpinning ligand binding and receptor oligomerization. J Med Chem. 2021;64(20):14997\u20135016. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00886.","journal-title":"J Med Chem"},{"key":"8297_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2018.01.042","volume":"133","author":"H Yano","year":"2018","unstructured":"Yano H, Bonifazi A, Xu M, Guthrie DA, Schneck SN, Abramyan AM, et al. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays. Neuropharmacology. 2018;133:264\u201375. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.042.","journal-title":"Neuropharmacology"},{"issue":"3","key":"8297_CR39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","volume":"131","author":"T Hayashi","year":"2007","unstructured":"Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER- Mitochondrion interface regulate Ca2+ signaling and cell survival. Cell. 2007;131(3):596\u2013610. https:\/\/doi.org\/10.1016\/j.cell.2007.08.036.","journal-title":"Cell"},{"issue":"3\u20134","key":"8297_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0891-0618(00)00106-X","volume":"20","author":"K Kitaichi","year":"2000","unstructured":"Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma1 (\u03c31) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat. 2000;20(3\u20134):375\u201387. https:\/\/doi.org\/10.1016\/S0891-0618(00)00106-X.","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"8297_CR41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1006\/bbrc.1996.1842","volume":"229","author":"R Kekuda","year":"1996","unstructured":"Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmar1). Biochem Bioph Res Co. 1996;229(2):553\u201358. https:\/\/doi.org\/10.1006\/bbrc.1996.1842.","journal-title":"Biochem Bioph Res Co"},{"issue":"8","key":"8297_CR42","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.3390\/cancers12082213","volume":"12","author":"L Villemain","year":"2020","unstructured":"Villemain L, Prigent S, Abou-Lovergne A, Pelletier L, Chiral M, Pontoglio M, et al. Sigma 1 receptor is overexpressed in hepatocellular adenoma: involvement of ER\u03b1 and HNF1\u03b1. Cancers (Basel). 2020;12(8):2213. https:\/\/doi.org\/10.3390\/cancers12082213.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8297_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13550-015-0122-2","volume":"5","author":"B Shen","year":"2015","unstructured":"Shen B, James ML, Andrews L, Lau C, Chen S, Palner M, et al. Further validation to support clinical translation of [18F]FTC-146 for imaging sigma-1 receptors. EJNMMI Res. 2015;5(1):49. https:\/\/doi.org\/10.1186\/s13550-015-0122-2.","journal-title":"EJNMMI Res"},{"issue":"1","key":"8297_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","volume":"268","author":"SB Hellewell","year":"1994","unstructured":"Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of \u03c31 and \u03c32 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Criminol Pharmacol: Mol Pharmacol. 1994;268(1):9\u201318. https:\/\/doi.org\/10.1016\/0922-4106(94)90115-5.","journal-title":"Eur J Criminol Pharmacol: Mol Pharmacol"},{"issue":"15","key":"8297_CR45","doi-asserted-by":"publisher","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","volume":"93","author":"M Hanner","year":"1996","unstructured":"Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA. 1996;93(15):8072\u201377. https:\/\/doi.org\/10.1073\/pnas.93.15.8072.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8297_CR46","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.neubiorev.2021.10.037","volume":"132","author":"K Sa\u0142aciak","year":"2022","unstructured":"Sa\u0142aciak K, Pytka K. Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders. Neurosci. Biobehav Rev. 2022;132:1114\u201336. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.10.037.","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"11","key":"8297_CR47","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1038\/s41591-025-03920-3","volume":"31","author":"R Reilmann","year":"2025","unstructured":"Reilmann R, Feigin A, Rosser AE, Kostyk SK, Saft C, Cohen Y, et al. Pridopidine in early-stage manifest Huntington\u2019s disease: a phase 3 trial. Nat Med. 2025;31(11):3780\u201389. https:\/\/doi.org\/10.1038\/s41591-025-03920-3.","journal-title":"Nat Med"},{"issue":"1","key":"8297_CR48","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/s41467-017-02087-x","volume":"8","author":"DO Sambo","year":"2017","unstructured":"Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, et al. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat Commun. 2017;8(1):2228. https:\/\/doi.org\/10.1038\/s41467-017-02087-x.","journal-title":"Nat Commun"},{"key":"8297_CR49","doi-asserted-by":"publisher","first-page":"1143648","DOI":"10.3389\/fmicb.2023.1143648","volume":"14","author":"JH Li","year":"2023","unstructured":"Li JH, Liu JL, Li XW, Liu Y, Yang JZ, Chen LJ, et al. Gut microbiota from sigma-1 receptor knockout mice induces depression-like behaviors and modulates the cAMP\/CREB\/BDNF signaling pathway. Front Microbiol. 2023;14:1143648. https:\/\/doi.org\/10.3389\/fmicb.2023.1143648.","journal-title":"Front Microbiol"},{"key":"8297_CR50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbi.2024.06.008","volume":"120","author":"JY Wang","year":"2024","unstructured":"Wang JY, Ren P, Cui LY, Duan JY, Chen HL, Zeng ZR, et al. Astrocyte-specific activation of sigma-1 receptors in mPFC mediates the faster onset antidepressant effect by inhibiting NF-\u03baB-induced neuroinflammation. Brain Behav Immun. 2024;120:256\u201374. https:\/\/doi.org\/10.1016\/j.bbi.2024.06.008.","journal-title":"Brain Behav Immun"},{"issue":"22","key":"8297_CR51","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1021\/acschemneuro.2c00629","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Gao T, Jia X, Gao C, Tian H, Wei Y, et al. SKF83959 attenuates memory impairment and depressive-like behavior during the latent period of epilepsy via allosteric activation of the Sigma-1 receptor. ACS Chem Neurosci. 2022;13(22):3198\u2013209. https:\/\/doi.org\/10.1021\/acschemneuro.2c00629.","journal-title":"ACS Chem. Neurosci"},{"issue":"4","key":"8297_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/ph18040455","volume":"18","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhang Y, Hou X, Li H, Ma H, Li Y. Hypidone hydrochloride (YL-0919), a Sigma-1 receptor agonist, improves attention by increasing BDNF in mPFC. Pharmaceuticals (Basel). 2025;18(4):455. https:\/\/doi.org\/10.3390\/ph18040455.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"8297_CR53","doi-asserted-by":"publisher","first-page":"100016","DOI":"10.1016\/j.tjpad.2024.100016","volume":"12","author":"S Macfarlane","year":"2025","unstructured":"Macfarlane S, Grimmer T, Teo K, O\u2019Brien TJ, Woodward M, Grunfeld J, et al. Blarcamesine for the treatment of early Alzheimer\u2019s disease: results from the ANAVEX2-73-AD-004 phase IIB\/III trial. J Sport Hist Prev Alzheimers Disease. 2025;12(1):100016. https:\/\/doi.org\/10.1016\/j.tjpad.2024.100016.","journal-title":"J Sport Hist Prev Alzheimers Disease"},{"issue":"1","key":"8297_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10020-021-00325-z","volume":"27","author":"C Zhang","year":"2021","unstructured":"Zhang C, Shi X, Su Z, Hu C, Mu X, Pan J, et al. CD36 deficiency ameliorates drug-induced acute liver injury in mice. Mol Med. 2021;27(1):57. https:\/\/doi.org\/10.1186\/s10020-021-00325-z.","journal-title":"Mol Med"},{"issue":"4","key":"8297_CR55","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.6A0114-004RR","volume":"96","author":"M Wang","year":"2014","unstructured":"Wang M, You Q, Lor K, Chen F, Gao B, Ju C. Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice. J Leukoc Biol. 2014;96(4):657\u201365. https:\/\/doi.org\/10.1189\/jlb.6A0114-004RR.","journal-title":"J Leukoc Biol"},{"key":"8297_CR56","doi-asserted-by":"publisher","unstructured":"Sun Z, Zhang B, Zhou J, Luo Y, Zhu X, Wang Y, et al. Integrated single-cell RNA-seq and ATAC-seq reveals heterogeneous differentiation of CD4 + naive T cell subsets is associated with response to antidepressant treatment in major depressive disorder. Adv Sci. 2024;11(30):e2308393. https:\/\/doi.org\/10.1002\/advs.202308393.","DOI":"10.1002\/advs.202308393"},{"issue":"7","key":"8297_CR57","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888\u2013902.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031.","journal-title":"Cell"},{"issue":"6335","key":"8297_CR58","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1126\/science.aah4573","volume":"356","author":"AC Villani","year":"2017","unstructured":"Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356(6335):6335. https:\/\/doi.org\/10.1126\/science.aah4573.","journal-title":"Science"},{"issue":"17","key":"8297_CR59","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.7150\/thno.36037","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang J, Li Y. CD36 tango in cancer: signaling pathways and functions. Theranostics. 2019;9(17):4893\u2013908. https:\/\/doi.org\/10.7150\/thno.36037.","journal-title":"Theranostics"},{"key":"8297_CR60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jare.2024.02.017","volume":"68","author":"Z Gao","year":"2025","unstructured":"Gao Z, Gao Y, Li Y, Zhou J, Li G, Xie S, et al. 5-HT7R enhances neuroimmune resilience and alleviates meningitis by promoting CCR5 ubiquitination. J Adv Res. 2025;68:317\u201330. https:\/\/doi.org\/10.1016\/j.jare.2024.02.017.","journal-title":"J Adv Res"},{"issue":"10","key":"8297_CR61","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1038\/s41380-025-03085-y","volume":"30","author":"X Feng","year":"2025","unstructured":"Feng X, Jia M, Cai M, Zhu T, Hashimoto K, Yang JJ. Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research. Mol Psychiatry. 2025;30(10):4881\u201398. https:\/\/doi.org\/10.1038\/s41380-025-03085-y.","journal-title":"Mol. Psychiatry"},{"key":"8297_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jad.2022.10.015","volume":"321","author":"J Ren","year":"2023","unstructured":"Ren J, Wu Z, Peng D, Huang J, Xia W, Xu J, et al. Changes of anhedonia and cognitive symptoms in first episode of depression and recurrent depression, an analysis of data from NSSD. J Educ Chang Affective Disord. 2023;321:47\u201355. https:\/\/doi.org\/10.1016\/j.jad.2022.10.015.","journal-title":"J Educ Chang Affective Disord"},{"issue":"11","key":"8297_CR63","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S2215-0366(24)00291-8","volume":"11","author":"K Flinkenfl\u00fcgel","year":"2024","unstructured":"Flinkenfl\u00fcgel K, Meinert S, Hirtsiefer C, Grotegerd D, Gruber M, Goltermann J, et al. Associations between white matter microstructure and cognitive decline in major depressive disorder versus controls in Germany: a prospective case-control cohort study. Lancet Psychiatry. 2024;11(11):899\u2013909. https:\/\/doi.org\/10.1016\/S2215-0366(24)00291-8.","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"8297_CR64","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1038\/s41380-022-01715-3","volume":"27","author":"M Bekhbat","year":"2022","unstructured":"Bekhbat M, Li Z, Mehta ND, Treadway MT, Lucido MJ, Woolwine BJ, et al. Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Mol Psychiatry. 2022;27(10):4113\u201321. https:\/\/doi.org\/10.1038\/s41380-022-01715-3.","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"8297_CR65","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41380-024-02751-x","volume":"30","author":"MT Treadway","year":"2025","unstructured":"Treadway MT, Etuk SM, Cooper JA, Hossein S, Hahn E, Betters SA, et al. A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation. Mol Psychiatry. 2025;30(4):1407\u201317. https:\/\/doi.org\/10.1038\/s41380-024-02751-x.","journal-title":"Mol. Psychiatry"},{"key":"8297_CR66","doi-asserted-by":"publisher","unstructured":"Li Y, Zhao C, Sun S, Mi G, Liu C, Ding G, et al. Elucidating the bidirectional association between autoimmune diseases and depression: a systematic review and meta-analysis. BMJ Ment Health. 2024;27(1):e301252. https:\/\/doi.org\/10.1136\/bmjment-2024-301252.","DOI":"10.1136\/bmjment-2024-301252"},{"key":"8297_CR67","doi-asserted-by":"publisher","first-page":"1048592","DOI":"10.3389\/fimmu.2023.1048592","volume":"14","author":"JY Lai","year":"2023","unstructured":"Lai JY, Ho JX, Kow ASF, Liang G, Tham CL, Ho YC, et al. Interferon therapy and its association with depressive disorders \u2013 a review. Front Immunol. 2023;14:1048592. https:\/\/doi.org\/10.3389\/fimmu.2023.1048592.","journal-title":"Front Immunol"},{"key":"8297_CR68","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5, 166 patients and 5, 083 controls. Brain Behav Immun. 2020;87:901\u201309. https:\/\/doi.org\/10.1016\/j.bbi.2020.02.010.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"8297_CR69","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41398-024-02902-2","volume":"14","author":"FM Daray","year":"2024","unstructured":"Daray FM, Grendas LN, R \u00c1R, Tifner V, \u00c1lvarez Casiani RI, Olaviaga A, et al. Decoding the inflammatory signature of the major depressive episode: insights from peripheral immunophenotyping in active and remitted condition, a case\u2013control study. Transl Psychiatry. 2024;14(1):254. https:\/\/doi.org\/10.1038\/s41398-024-02902-2.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"8297_CR70","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1038\/s41380-020-00867-4","volume":"26","author":"N Mac Giollabhui","year":"2021","unstructured":"Mac Giollabhui N, Ng TH, Ellman LM, Alloy LB. The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression. Mol. Psychiatry. 2021;26(7):3302\u201314. https:\/\/doi.org\/10.1038\/s41380-020-00867-4.","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"8297_CR71","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1017\/S0033291719001454","volume":"49","author":"EF Osimo","year":"2019","unstructured":"Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019;49(12):1958\u201370. https:\/\/doi.org\/10.1017\/S0033291719001454.","journal-title":"Psychol Med"},{"key":"8297_CR72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache D, Pariante CM, Mondelli V. Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun. 2019;81:24\u201340. https:\/\/doi.org\/10.1016\/j.bbi.2019.06.015.","journal-title":"Brain Behav Immun"},{"key":"8297_CR73","doi-asserted-by":"publisher","first-page":"981442","DOI":"10.3389\/fnmol.2022.981442","volume":"15","author":"B Eggerstorfer","year":"2022","unstructured":"Eggerstorfer B, Kim JH, Cumming P, Lanzenberger R, Gryglewski G. Meta-analysis of molecular imaging of translocator protein in major depression. Front Mol Neurosci. 2022;15:981442. https:\/\/doi.org\/10.3389\/fnmol.2022.981442.","journal-title":"Front Mol Neurosci"},{"key":"8297_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.011","volume":"83","author":"H Li","year":"2018","unstructured":"Li H, Sagar AP, K\u00e9ri S. Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2018;83:1\u20137. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.12.011.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8297_CR75","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.phrs.2024.107322","volume":"207","author":"Y Yin","year":"2024","unstructured":"Yin Y, Ju T, Zeng D, Duan F, Zhu Y, Liu J, et al. \u201cInflamed\u201d depression: a review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression. Pharmacological Res. 2024;207:107322. https:\/\/doi.org\/10.1016\/j.phrs.2024.107322.","journal-title":"Pharmacological Res"},{"key":"8297_CR76","doi-asserted-by":"publisher","first-page":"1130989","DOI":"10.3389\/fpsyt.2023.1130989","volume":"14","author":"S Hassamal","year":"2023","unstructured":"Hassamal S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front Psychiatry. 2023;14:1130989. https:\/\/doi.org\/10.3389\/fpsyt.2023.1130989.","journal-title":"Front. Psychiatry"},{"issue":"1","key":"8297_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12974-024-03312-3","volume":"22","author":"W Jiao","year":"2025","unstructured":"Jiao W, Lin J, Deng Y, Ji Y, Liang C, Wei S, et al. The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms. J Neuroinflammation. 2025;22(1):10. https:\/\/doi.org\/10.1186\/s12974-024-03312-3.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"8297_CR78","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/biom15040502","volume":"15","author":"A S\u0103lcudean","year":"2025","unstructured":"S\u0103lcudean A, Bodo CR, Popovici RA, Cozma MM, P\u0103curar M, Cr\u0103ciun RE, et al. Neuroinflammation\u2014A crucial factor in the pathophysiology of depression\u2014a comprehensive review. Biomolecules. 2025;15(4):502. https:\/\/doi.org\/10.3390\/biom15040502.","journal-title":"Biomolecules"},{"issue":"17","key":"8297_CR79","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.3390\/ijms26178361","volume":"26","author":"H Siuchni\u0144ska","year":"2025","unstructured":"Siuchni\u0144ska H, Minarowska A, Wasilewska E. Beyond joints: neuropsychiatric benefits of TNF-\u03b1 and IL-6 inhibitors in rheumatoid arthritis\u2014narrative review. IJMS. 2025;26(17):8361. https:\/\/doi.org\/10.3390\/ijms26178361.","journal-title":"IJMS"},{"issue":"2","key":"8297_CR80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2018","unstructured":"Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol. Psychiatry. 2018;23(2):335\u201343. https:\/\/doi.org\/10.1038\/mp.2016.167.","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"8297_CR81","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31\u201341. https:\/\/doi.org\/10.1001\/2013.jamapsychiatry.4.","journal-title":"JAMA Psychiatry"},{"key":"8297_CR82","doi-asserted-by":"publisher","first-page":"1045759","DOI":"10.3389\/fcell.2023.1045759","volume":"11","author":"J Zhao","year":"2023","unstructured":"Zhao J, Veeranan-Karmegam R, Baker FC, Mysona BA, Bagchi P, Liu Y, et al. Defining the ligand-dependent proximatome of the sigma 1 receptor. Front. Cell Dev. Biol. 2023;11:1045759. https:\/\/doi.org\/10.3389\/fcell.2023.1045759.","journal-title":"Front. Cell Dev. Biol"},{"issue":"1","key":"8297_CR83","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41467-022-28946-w","volume":"13","author":"F Meng","year":"2022","unstructured":"Meng F, Xiao Y, Ji Y, Sun Z, Zhou X. An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway. Nat Commun. 2022;13(1):1267. https:\/\/doi.org\/10.1038\/s41467-022-28946-w.","journal-title":"Nat Commun"},{"issue":"27","key":"8297_CR84","doi-asserted-by":"publisher","first-page":"11250","DOI":"10.1074\/jbc.M116.774075","volume":"292","author":"WC Hong","year":"2017","unstructured":"Hong WC, Yano H, Hiranita T, Chin FT, McCurdy CR, Su TP, et al. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. J Biol Chem. 2017;292(27):11250\u201361. https:\/\/doi.org\/10.1074\/jbc.M116.774075.","journal-title":"J Biol Chem"},{"issue":"7","key":"8297_CR85","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/s41401-021-00807-0","volume":"43","author":"YM Zhang","year":"2022","unstructured":"Zhang YM, Ye LY, Li TY, Guo F, Guo F, Li Y, et al. New monoamine antidepressant, hypidone hydrochloride (YL-0919), enhances the excitability of medial prefrontal cortex in mice via a neural disinhibition mechanism. Acta Pharmacol Sin. 2022;43(7):1699\u2013709. https:\/\/doi.org\/10.1038\/s41401-021-00807-0.","journal-title":"Acta Pharmacol Sin"},{"key":"8297_CR86","doi-asserted-by":"publisher","first-page":"111524","DOI":"10.1016\/j.intimp.2024.111524","volume":"128","author":"Z Gao","year":"2024","unstructured":"Gao Z, Xie S, Wang L, Jiang L, Zhou J, Liang M, et al. Hypidone hydrochloride (YL-0919) protects mice from meningitis via Sigma1R-STAT1-NLRP3-GSDMD pathway. Int Immunopharmacol. 2024;128:111524. https:\/\/doi.org\/10.1016\/j.intimp.2024.111524.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"8297_CR87","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41418-020-00702-x","volume":"28","author":"BK Fiil","year":"2021","unstructured":"Fiil BK, Gyrd-Hansen M. The Met1-linked ubiquitin machinery in inflammation and infection. Cell Death Differ. 2021;28(2):557\u201369. https:\/\/doi.org\/10.1038\/s41418-020-00702-x.","journal-title":"Cell Death Differ"},{"issue":"1","key":"8297_CR88","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41467-025-67219-0","volume":"17","author":"L Zhao","year":"2025","unstructured":"Zhao L, He Z, Sun Y, Sun M, Liu Z, Zhou Z, et al. Ubiquitination by HRD1 is essential for TLR3 trafficking and its innate immune signaling. Nat Commun. 2025;17(1):525. https:\/\/doi.org\/10.1038\/s41467-025-67219-0.","journal-title":"Nat Commun"},{"issue":"1","key":"8297_CR89","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41398-021-01529-x","volume":"11","author":"S Belaish","year":"2021","unstructured":"Belaish S, Israel-Elgali I, Shapira G, Krieger I, Segev A, Nitzan U, et al. Genome wide analysis implicates upregulation of proteasome pathway in major depressive disorder. Transl Psychiatry. 2021;11(1):409. https:\/\/doi.org\/10.1038\/s41398-021-01529-x.","journal-title":"Transl Psychiatry"},{"key":"8297_CR90","doi-asserted-by":"publisher","unstructured":"Minelli A, Magri C, Barbon A, Bonvicini C, Segala M, Congiu C, et al. Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder. Transl Psychiatry. 2015;5(12):e687. https:\/\/doi.org\/10.1038\/tp.2015.180.","DOI":"10.1038\/tp.2015.180"},{"key":"8297_CR91","doi-asserted-by":"publisher","first-page":"106625","DOI":"10.1016\/j.phrs.2022.106625","volume":"187","author":"CY Xia","year":"2023","unstructured":"Xia CY, Guo YX, Lian WW, Yan Y, Ma BZ, Cheng YC, et al. The NLRP3 inflammasome in depression: potential mechanisms and therapies. Pharmacological Res. 2023;187:106625. https:\/\/doi.org\/10.1016\/j.phrs.2022.106625.","journal-title":"Pharmacological Res"},{"issue":"1","key":"8297_CR92","doi-asserted-by":"publisher","first-page":"13727","DOI":"10.1038\/ncomms13727","volume":"7","author":"H Song","year":"2016","unstructured":"Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016;7(1):13727. https:\/\/doi.org\/10.1038\/ncomms13727.","journal-title":"Nat Commun"},{"issue":"1","key":"8297_CR93","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1038\/s41467-020-19939-8","volume":"11","author":"H Song","year":"2020","unstructured":"Song H, Zhao C, Yu Z, Li Q, Yan R, Qin Y, et al. UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression. Nat Commun. 2020;11(1):6042. https:\/\/doi.org\/10.1038\/s41467-020-19939-8.","journal-title":"Nat Commun"},{"key":"8297_CR94","doi-asserted-by":"publisher","first-page":"111324","DOI":"10.1016\/j.intimp.2023.111324","volume":"127","author":"T Gao","year":"2024","unstructured":"Gao T, Wang T, Wu L, Tong Y, Tian J, Zhao K, et al. Saikosaponin-d alleviates depression by promoting NLRP3 ubiquitination and inhibiting inflammasome activation. Int Immunopharmacol. 2024;127:111324. https:\/\/doi.org\/10.1016\/j.intimp.2023.111324.","journal-title":"Int Immunopharmacol"},{"key":"8297_CR95","doi-asserted-by":"publisher","first-page":"984475","DOI":"10.3389\/fphar.2022.984475","volume":"13","author":"M Xie","year":"2022","unstructured":"Xie M, Wang H, Peng J, Qing D, Zhang X, Guo D, et al. Acacetin protects against depression-associated dry eye disease by regulating ubiquitination of NLRP3 through gp78 signal. Front Pharmacol. 2022;13:984475. https:\/\/doi.org\/10.3389\/fphar.2022.984475.","journal-title":"Front Pharmacol"},{"issue":"8","key":"8297_CR96","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41419-020-02888-x","volume":"11","author":"X Xia","year":"2020","unstructured":"Xia X, Xu Q, Liu M, Chen X, Liu X, He J, et al. Deubiquitination of CD36 by UCHL1 promotes foam cell formation. Cell Death Dis. 2020;11(8):636. https:\/\/doi.org\/10.1038\/s41419-020-02888-x.","journal-title":"Cell Death Dis"},{"issue":"4","key":"8297_CR97","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/ehf2.14423","volume":"10","author":"M Zeng","year":"2023","unstructured":"Zeng M, Wei X, He Y, Yang Y. Ubiquitin-specific protease 11-mediated CD36 deubiquitination acts on C1q\/TNF-related protein 9 against atherosclerosis. ESC Heart Fail. 2023;10(4):2499\u2013509. https:\/\/doi.org\/10.1002\/ehf2.14423.","journal-title":"ESC Heart Fail"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08297-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08297-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08297-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:10Z","timestamp":1784851210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08297-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8297"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08297-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The clinical data used in this study were sourced from publicly available databases (as detailed in the Methods section). Ethical approval and participant consent were the responsibility of the data providers and the hosting platforms, and were obtained as part of the original projects. This study strictly adhered to the data usage terms and academic standards set by the platform and did not involve the collection of any new human samples. The animal studies were approved by the Institutional Animal Care and Use Committee at the Beijing Institute of Basic Medical Sciences (IACUC-DWZX-2021-645). The studies were conducted in accordance with the local legislation and institutional requirements.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"951"}}